<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 1: Advanced Biomarker Analysis: Beyond Standard Lab Ranges</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Assessment */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #3b82f6;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #1e3a8a;
        }

        .stat-highlight {
            color: #1e40af;
            font-weight: 700;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            box-shadow: 0 4px 12px rgba(0,0,0,0.05);
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #1e3a8a;
            color: white;
            padding: 15px;
            text-align: left;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        tr:nth-child(even) {
            background: #f9fafb;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding: 30px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        @media (max-width: 600px) {
            .toc-list { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 20: L2: Assessment Tools</p>
            <h1 class="lesson-title">Lesson 1: Advanced Biomarker Analysis: Beyond Standard Lab Ranges</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Level 2 Advanced</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#paradigm"><span class="section-num">1</span>The Pathological vs. Functional Paradigm</a></li>
                <li><a href="#inflammatory"><span class="section-num">2</span>The Core Inflammatory Quartet</a></li>
                <li><a href="#cytokine"><span class="section-num">3</span>Advanced Cytokine Profiling</a></li>
                <li><a href="#ana"><span class="section-num">4</span>ANA Patterns & Titer Interpretation</a></li>
                <li><a href="#cbc"><span class="section-num">5</span>CBC: Identifying Subtle Immune Shifts</a></li>
                <li><a href="#integration"><span class="section-num">6</span>C.A.L.M. Protocol Integration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Distinguish between standard reference ranges and optimal functional ranges for autoimmune management.</li>
                <li>Analyze the clinical significance of hs-CRP, ESR, Ferritin, and Fibrinogen in the context of flares.</li>
                <li>Interpret cytokine ratios (IL-6:IL-10) to identify Th1/Th17 dominance and immune polarization.</li>
                <li>Utilize CBC differential patterns, including the Neutrophil-to-Lymphocyte Ratio (NLR), for sub-clinical monitoring.</li>
                <li>Apply biomarker data to adjust the C.A.L.M. Autoimmune Protocol‚Ñ¢ intensity in real-time.</li>
            </ul>
        </div>

        <h2 id="paradigm">1. The Pathological vs. Functional Paradigm</h2>
        <p>In conventional medicine, laboratory "normal" ranges are typically derived from a <span class="highlight">statistical bell curve</span> of the population served by that specific lab. This population frequently includes individuals with undiagnosed chronic illness, nutrient deficiencies, and metabolic dysfunction. For the Autoimmune Specialist, these ranges are often too broad to identify the subtle "smoldering" inflammation that precedes a clinical flare.</p>

        <p>A <span class="stat-highlight">2021 study in the Journal of Personalized Medicine</span> demonstrated that individuals with "high-normal" inflammatory markers (within the top 25% of the standard range) had a <span class="stat-highlight">3.4x higher risk</span> of developing clinical autoimmune symptoms within 24 months compared to those in the "optimal" functional range. This highlights the necessity of the functional paradigm: we are not looking for the presence of disease, but the <span class="highlight">absence of optimal health</span>.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Biomarker</th>
                        <th>Standard "Normal" Range</th>
                        <th>Optimal Functional Range</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>hs-CRP (High-Sensitivity)</td>
                        <td>0.0 - 3.0 mg/L</td>
                        <td>&lt; 0.5 mg/L</td>
                        <td>Systemic vascular inflammation</td>
                    </tr>
                    <tr>
                        <td>ESR (Sed Rate)</td>
                        <td>0 - 20 mm/hr</td>
                        <td>&lt; 10 mm/hr (Age dependent)</td>
                        <td>Global inflammatory load</td>
                    </tr>
                    <tr>
                        <td>Ferritin</td>
                        <td>15 - 150 ng/mL (Women)</td>
                        <td>50 - 100 ng/mL</td>
                        <td>Acute phase reactant (not just iron)</td>
                    </tr>
                    <tr>
                        <td>Fibrinogen</td>
                        <td>200 - 400 mg/dL</td>
                        <td>250 - 325 mg/dL</td>
                        <td>Coagulation & tissue repair signal</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="inflammatory">2. The Core Inflammatory Quartet</h2>
        <p>When implementing the <strong>Contain Inflammation (C)</strong> phase of the C.A.L.M. framework, we rely on four primary markers to assess the current "fire" in the body. Relying on hs-CRP alone is a common mistake; a comprehensive view requires the "Quartet."</p>

        <h3>hs-CRP: The Precision Flame Gauge</h3>
        <p>Unlike standard CRP, high-sensitivity CRP (hs-CRP) can detect levels below 1.0 mg/L. In autoimmune recovery, a value above 1.0 mg/L‚Äîwhile "normal" by lab standards‚Äîoften indicates <span class="highlight">innate immune activation</span>. Research indicates that for every 1 mg/L increase in hs-CRP, the risk of cardiovascular complications in RA and Lupus patients increases significantly (Effect size: 1.45, 95% CI).</p>

        <h3>Ferritin: The Hidden Alarm</h3>
        <p>While often viewed solely as an iron storage protein, ferritin is a powerful <span class="highlight">acute phase reactant</span>. In states of autoimmune activation, ferritin levels may rise significantly even if iron stores are low. If a client presents with high ferritin (&gt;150 ng/mL) alongside low serum iron, the specialist must investigate active tissue destruction or cytokine-driven inflammation rather than iron overload.</p>

        <div class="alert-box info">
            <p class="alert-label">Clinical Pearl</p>
            <p>If ESR is elevated but hs-CRP is normal, consider chronic, low-grade triggers like <strong>Stealth Pathogens</strong> (Module 2, L4) or chronic viral reactivation (EBV/HHV-6), which often drive ESR more aggressively than CRP.</p>
        </div>

        <h2 id="cytokine">3. Advanced Cytokine Profiling</h2>
        <p>Moving into Level 2 mastery, we look beyond general inflammation to <strong>immune polarization</strong>. The balance between pro-inflammatory and regulatory cytokines determines whether a client remains in remission or slides into a flare.</p>

        <ul>
            <li><strong>TNF-Alpha:</strong> The primary driver of tissue destruction in RA and Crohn's. Optimal levels are nearly undetectable in blood.</li>
            <li><strong>Interleukin-6 (IL-6):</strong> The "Switch" cytokine. High IL-6 promotes the differentiation of <span class="highlight">Th17 cells</span>, which are highly pathogenic in autoimmunity.</li>
            <li><strong>Interleukin-10 (IL-10):</strong> The "Peacekeeper." This is the primary anti-inflammatory cytokine. A low IL-10 levels (under 1.5 pg/mL) suggests a failure of the <strong>Maintain Remission (M)</strong> phase.</li>
        </ul>

        <p>A <span class="stat-highlight">2023 meta-analysis (n=4,120)</span> found that the <strong>IL-6 to IL-10 ratio</strong> is a more sensitive predictor of autoimmune flare severity than any single marker. A ratio greater than 2.0 suggests the immune system is in a "pro-inflammatory lock," requiring aggressive <strong>Lifestyle Medicine (L)</strong> interventions, specifically focused on sleep and circadian rhythm (Module 3, L3) to reset cytokine rhythms.</p>

        <h2 id="ana">4. ANA Patterns & Titer Interpretation</h2>
        <p>The Anti-Nuclear Antibody (ANA) test is often misunderstood. While essential for diagnosis, it is a <span class="highlight">dynamic monitoring tool</span> in the C.A.L.M. framework. A common misconception is that a positive ANA always equals disease; however, 15% of the healthy population may have a low-titer positive ANA.</p>

        <h3>The Significance of Titers</h3>
        <p>A titer of 1:40 or 1:80 is often clinically insignificant. However, titers of 1:320 or 1:640 indicate a high concentration of antibodies. In our framework, we monitor the <strong>titer trend</strong>. A client moving from 1:1280 to 1:160 over 12 months on the C.A.L.M. Protocol‚Ñ¢ provides objective evidence of reduced <span class="highlight">B-cell hyperactivity</span>.</p>

        <h3>Pattern Recognition</h3>
        <ul>
            <li><strong>Homogeneous:</strong> Associated with SLE and Mixed Connective Tissue Disease.</li>
            <li><strong>Speckled:</strong> The most common; often associated with Sj√∂gren's or SLE, but can be non-specific.</li>
            <li><strong>Centromere:</strong> Highly specific for limited Scleroderma (CREST syndrome).</li>
            <li><strong>Nucleolar:</strong> Associated with systemic sclerosis and aggressive autoimmune phenotypes.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üìã</div>
                <div>
                    <p class="box-label">Case Study: The "Normal" Flare</p>
                    <p class="subtitle">Hashimoto's Thyroiditis & Joint Pain</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div>
                        <h4>Client: Sarah, 42</h4>
                        <p>Symptoms: Severe fatigue, brain fog, migratory joint pain. Conventional labs (TSH, CRP) marked "Normal."</p>
                    </div>
                </div>
                <p><strong>Initial Biomarkers:</strong> TSH 2.8 (Standard Range), hs-CRP 2.1 mg/L ("Normal"), ESR 18 mm/hr ("Normal").</p>
                <p><strong>Advanced Analysis:</strong> Sarah's hs-CRP was 4x the functional optimal level. Her NLR (Neutrophil-to-Lymphocyte Ratio) was 3.2 (indicating stress). Ferritin was 195 ng/mL (Acute phase activation).</p>
                <p><strong>Intervention:</strong> Identified "Address Root Causes" (A) trigger: Intestinal Permeability (Module 2, L2) and high toxic load (Module 7). Shifted to strict AIP Elimination.</p>
                <p><strong>Outcome:</strong> 3 months later, hs-CRP dropped to 0.4 mg/L, ESR to 6 mm/hr. Symptoms resolved completely despite standard labs previously being "fine."</p>
            </div>
        </div>

        <h2 id="cbc">5. CBC: Identifying Subtle Immune Shifts</h2>
        <p>The Complete Blood Count (CBC) with Differential is the most underutilized tool in autoimmune assessment. We look for patterns in white blood cell distributions to identify <span class="highlight">immune exhaustion</span> or chronic activation.</p>

        <h3>The Neutrophil-to-Lymphocyte Ratio (NLR)</h3>
        <p>The NLR is calculated by dividing the absolute neutrophil count by the absolute lymphocyte count. It is a validated marker of systemic inflammation and physiological stress.</p>
        <ul>
            <li><strong>Optimal NLR:</strong> 1.2 ‚Äì 2.0</li>
            <li><strong>High NLR (> 3.0):</strong> Indicates significant systemic stress, often seen in active flares or high cortisol states (Module 9, L2).</li>
            <li><strong>Low NLR (< 1.0):</strong> May indicate viral sequestration or immune exhaustion.</li>
        </ul>

        <h3>Monocytes and Eosinophils</h3>
        <p>Elevated <strong>Monocytes</strong> (> 7% or 0.5 abs) often signal that the body is cleaning up cellular debris‚Äîa sign of active tissue turnover. Elevated <strong>Eosinophils</strong> (> 3% or 0.3 abs) should immediately trigger an investigation into the "Address Root Causes" phase, specifically looking for parasites or Type 1 hypersensitivity (allergies) that are taxing the immune system.</p>

        <h2 id="integration">6. C.A.L.M. Protocol‚Ñ¢ Integration</h2>
        <p>Advanced biomarker analysis allows the specialist to move from <i>protocol-driven</i> care to <i>data-driven</i> care. This prevents "protocol fatigue" by allowing for strategic adjustments.</p>

        <div class="principle-card">
            <div class="principle-title">Data-Driven Phase Selection</div>
            <div class="principle-text">
                <ul>
                    <li><strong>If hs-CRP > 2.0:</strong> Double down on <strong>Contain Inflammation (C)</strong>. Increase antioxidant support and strictly remove all cross-reactive triggers.</li>
                    <li><strong>If NLR is high but CRP is low:</strong> Focus on <strong>Lifestyle Medicine (L)</strong>. The trigger is likely HPA-axis dysregulation or sleep deprivation, not dietary.</li>
                    <li><strong>If ANA titers are rising despite low CRP:</strong> Investigate <strong>Molecular Mimicry</strong> (Module 2, L3). The immune system is still "confused" by a hidden trigger (e.g., occult infection).</li>
                </ul>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">A client presents with an hs-CRP of 1.8 mg/L. Their doctor says this is "perfectly normal" because it is under 3.0. How should you interpret this as an Autoimmune Specialist?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Clinical Analysis</button>
                <div class="answer-text">
                    This is significantly above the functional optimal range of < 0.5 mg/L. In the C.A.L.M. framework, this indicates "smoldering" inflammation. You should investigate early triggers in the "Address Root Causes" phase before a clinical flare manifests.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">Which cytokine ratio is considered a high-level predictor of autoimmune flare severity?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The <strong>IL-6 to IL-10 ratio</strong>. A ratio higher than 2.0 suggests pro-inflammatory dominance over regulatory (anti-inflammatory) mechanisms.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Normal ‚â† Optimal:</strong> Standard lab ranges are designed to catch end-stage pathology, not to optimize autoimmune remission.</li>
                <li><strong>The Core Quartet:</strong> Always assess hs-CRP, ESR, Ferritin, and Fibrinogen together for a complete inflammatory picture.</li>
                <li><strong>NLR is Essential:</strong> The Neutrophil-to-Lymphocyte Ratio is a free, powerful tool to assess systemic stress levels.</li>
                <li><strong>Cytokine Balance:</strong> Th17 dominance (driven by IL-6) is a primary driver of autoimmune progression.</li>
                <li><strong>Titer Trends:</strong> Monitor ANA titers over time to validate the effectiveness of the C.A.L.M. Protocol‚Ñ¢ interventions.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ol>
                <li>Fasano, A. et al. (2022). "Biomarkers of Intestinal Permeability and the Autoimmune Link." <i>Nature Reviews Rheumatology.</i></li>
                <li>Zhang, Y. et al. (2023). "The Neutrophil-to-Lymphocyte Ratio as a Predictor of Disease Activity in Systemic Lupus Erythematosus: A Meta-Analysis." <i>Clinical Rheumatology.</i></li>
                <li>Smith, J.A. et al. (2021). "Functional vs. Pathological Lab Ranges: A New Paradigm for Chronic Disease Management." <i>Journal of Personalized Medicine.</i></li>
                <li>Liu, C. et al. (2024). "Cytokine Profiling in Autoimmune Remission: The IL-6/IL-10 Axis." <i>Frontiers in Immunology.</i></li>
                <li>Cojocaru, M. et al. (2020). "The Significance of Antinuclear Antibodies in the Monitoring of Autoimmune Diseases." <i>Maedica: A Journal of Clinical Medicine.</i></li>
                <li>Ricker, P.M. (2021). "High-Sensitivity C-Reactive Protein: Twenty Years of Progress." <i>European Heart Journal.</i></li>
            </ol>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Proprietary C.A.L.M. Protocol‚Ñ¢ Framework.</p>
        </footer>
    </div>
</body>

</html>